application of genetic testing in steroid-resistant nephrotic syndrome
Clicks: 264
ID: 208097
2018
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Steady Performance
30.0
/100
264 views
36 readers
AI Quality Assessment
Not analyzed
Readership in this journal
SteadyRanked #21 of 39 articles by views in oncology letters
Most read
Least read
Bar heights use a square-root scale.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
Nephrotic syndrome, one of the most frequent kidney conditions affecting patients of all ages, has significant genetic composition, especially in individuals who do not respond to glucocorticoid treatment. The recent developments in molecular biology transformed genetic testing into the first-line diagnostic tool in differential diagnosis of the condition. In this mini review current and future directions of genetic testing in nephrotic syndrome are presented.
| Reference Key |
lipska-zitkiewicz2018pokiapplication
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | ;B.S. Lipska-Ziętkiewicz |
| Journal | oncology letters |
| Year | 2018 |
| DOI |
10.22141/2307-1257.7.2.2018.127392
|
| URL | |
| Keywords |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.